Researchers identify a potential new therapeutic target in Parkinson’s disease

In a study published in Nature Communications, a team led by Krembil Brain Institute at UHN Senior Scientists, Drs. Lorraine Kalia and Suneil Kalia, and University of Toronto (U of T) Professor, Dr. Philip M. Kim, has identified a protein-protein interaction that contributes to Parkinson’s disease.

Leave A Comment

Your email address will not be published. Required fields are marked *